Marc Triola, MD, director of IIME, believes technology creates more—not fewer—opportunities for medical students.

Our surgeons developed a device to improve quality of life for people with early osteoarthritis of the knee.

Dr. Steven Abramson discusses how NYU School of Medicine has reinvented medical education.

Dr. Dafna Bar-Sagi discusses the future of biomedical research at NYU Langone Health.

Dr. Jan Vilcek describes the institutional support that helped make the widely-used drug Remicade happen.

NYU School of Medicine's three-year MD pathway eases the transition between medical school and residency.

Technology Ventures and Partnerships is pioneering academic drug discovery.

Our programs impart the skills required to launch a successful new venture in the biomedical industry.